Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 289-294

  Oliviero, Ugo ^a   Cittadini, Antonio ^a   Bosso, Giorgio ^a   Cerbone, Manuela ^a   Valvano, Antonio ^a   Capalbo, Donatella ^a   Apuzzi, Valentina ^a   Calabrese, Fabrizia ^a   Lettiero, Teresa ^a   Salerno, Mariacarolina ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADULT; AGED; ARTERY COMPLIANCE; ARTERY DISEASE; ARTERY DISTENSIBILITY IMPAIRMENT; ARTICLE; BRACHIAL ARTERY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PUBERTY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADOLESCENT; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CONGENITAL HYPOTHYROIDISM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PUBERTY; RISK FACTORS; THYROXINE; ULTRASONOGRAPHY, DOPPLER; VASODILATION; YOUNG ADULT;

EID: 75149142516     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0674     Document Type: Article

References (26)

1. Klein I & Ojamaa K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine 2001 344 501-519.
2. Cappola AR & Laderson PW. Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2003 88 2438-2444.
3. Owen PJ, Sabit R & Lazarus JH. Thyroid disease and vascular function. Thyroid 2007 17 519-524.
4. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000 10 665-679.
5. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Sugiguchi S, Fujiwara S, Emoto M, Ishimura E, Onoda N, Ishikawa T & Nishizawa Y. Decrease in carotid intima media thickness in hypothyroid patients after normalization of thyroid function. Clinical Endocrinology 2003 59 607-612.
6. Fazio S, Palmieri EA, Lombardi G & Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research 2004 59 31-50.
7. Cikim AS, Oflaz H, Ozbey N, Cikim K, Umman S, Meric M, Sencer E & Molvalilar S. Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 2004 14 605-609.
8. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J & Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. American Journal of Medicine 2006 119 541-551.
9. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP & Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. International Journal of Cardiology 2008 125 41-48.
10. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E & Monzani F. Impaired endotheliumdependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism 2003 88 3731-3737.
11. Erbil Y, Ozbey N, Giriş M, Salmaslioglu A, Özarmagan S & Tezelman S. Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. British Journal of Surgery 2007 94 1485-1490.
12. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C & Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism 2007 92 1715-1723.
13. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C & Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2004 89 2099-2106.
14. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Ishimura E, Onoda N, Ishikawa T & Nishizawa Y. Change in von Willebrand factor and carotid intima media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy. European Journal of Endocrinology 2004 150 125-131.
15. La Franchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999 9 735-740.
16. Gruters A, Biebermann H & Krude H. Neonatal thyroid disorders. Hormone Research 2003 59 24-29.
17. Salerno M, Oliviero U, Lettiero T, Guardasole V, Mattiacci DM, Saldamarco L, Capalbo D, Lucariello A, Saccà L & Cittadini A. Long-term cardiovascular effects of levothyroxine therapy in young adults with congenital hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2008 93 2486-2491.
18. McGill HC Jr, McMahan CA, Herderick EE, Tracy RE, Malcom GT, Zieske AW& Strong JP. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of aorta and right coronary artery. PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 836-845.
19. Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T & Tenore A. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. European Journal of Endocrinology 2001 145 377-383.
20. Corretti MC,Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfiled J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J & Vogel R. International brachial artery reactivity task force, guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. Journal of the American College of Cardiology 2002 39 257-265.
21. Nakamura M, Sugawara S, Arakawa N, Nagano M, Shizuka T, Shimoda Y, Sakai T & Hiramori K. Reduced vascular compliance is associated with impaired endothelium-dependent dilation in the brachial artery of patients with congestive heart failure. Journal of Cardiac Failure 2004 10 36-42.
22. Clausen P, Mersebach H, Nielsen B, Feldt-Rasmussen B & Feldt-Rasmussen U. Hypothyroidism is associated with signs of endothelial dysfunction despite one year replacement therapy with levothyroxine. Clinical Endocrinology 2009 70 932-937.
23. Drvota V, Janson A, Norman C, Sylvén C, Haggblad J, Bronnegard M & Marcus C. Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochemical and Biophysical Research Communications 1995 211 426-431.
24. Sellitti DF, Dennison D, Akamizu T, Doi AS, Kohn LD & Koshiyama H. Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. Thyroid 2000 10 219-225.
25. Donnini D, Ambesi-Impiombato FS & Curcio F. Thyrotropin stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 2003 13 517-521.
26. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A & Monzani F. Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2006 91 4175-4178.